Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ENLIGHTEN: Establishing Novel Antiretroviral Imaging for Hair to Elucidate Non-Adherence

Trial Profile

ENLIGHTEN: Establishing Novel Antiretroviral Imaging for Hair to Elucidate Non-Adherence

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Feb 2019

At a glance

  • Drugs Dolutegravir (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Maraviroc (Primary)
  • Indications HIV infections
  • Focus Pharmacokinetics
  • Acronyms ENLIGHTEN
  • Most Recent Events

    • 07 Feb 2019 Status changed from active, no longer recruiting to completed.
    • 04 Dec 2018 Planned End Date changed from 30 Mar 2019 to 7 Dec 2018.
    • 21 Sep 2018 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top